Meera Tugnait
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 8
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 5
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 6
-
- Chronic Myeloid Leukemia Treatments 6
-
- Analytical Chemistry and Chromatography 4
-
- Eosinophilic Disorders and Syndromes 4
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Mast cells and histamine 3
- Co-authors
- Narayana I. NarasimhanDavid KersteinDavid J. DorerEdward M. HawesFrank G. HaluskaVincent MascittiLyudmila BazhenovaRavi Salgia
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Meera Tugnait
23 papers receiving 897 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 148
- Endocrinology, Diabetes and Metabolism 230
- Oncology 308
- Genetics 105
- Pulmonary and Respiratory Medicine 315
Countries citing papers authored by Meera Tugnait
This map shows the geographic impact of Meera Tugnait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meera Tugnait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meera Tugnait more than expected).
Fields of papers citing papers by Meera Tugnait
This network shows the impact of papers produced by Meera Tugnait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meera Tugnait. The network helps show where Meera Tugnait may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meera Tugnait, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 88 | |
| 5 | 2021 | 7 | |
| 6 | 2019 | 19 | |
| 7 | 2016 | 261 | |
| 8 | 2013 | 44 | |
| 9 | 2012 | 102 | |
| 10 | 2011 | 28 | |
| 11 | 2011 | 59 | |
| 12 | 2011 | 48 | |
| 13 | 2005 | 22 | |
| 14 | 2005 | 16 | |
| 15 | 2002 | 9 | |
| 16 | 2002 | 13 | |
| 17 | 2002 | 7 | |
| 18 | 1999 | 50 | |
| 19 | N-oxygenation of clozapine by flavin-containing monooxygenase. | 1997 | 59 |
| 20 | 1991 | 8 |
About Meera Tugnait
Meera Tugnait is a scholar working on Pharmacology, Genetics and Hematology, having authored 25 papers that have together received 912 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Analytical Chemistry and Chromatography (4 papers), Eosinophilic Disorders and Syndromes (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Mast cells and histamine (3 papers). The work is most often cited by research in Pharmacology (148 citations), Endocrinology, Diabetes and Metabolism (230 citations) and Oncology (308 citations). Meera Tugnait has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Narayana I. Narasimhan, David Kerstein, David J. Dorer, Edward M. Hawes, Frank G. Haluska, Vincent Mascitti, Lyudmila Bazhenova, Ravi Salgia, David Ross Camidge and Alice T. Shaw. Their work appears in journals such as Nature Medicine, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.